Lung Cancer Research Lung Cancer Research

Lung cancer is the leading cancer killer in both men and women in the United States.1 About 90% of people diagnosed with lung cancer will die from the disease2, and Boston Scientific is committed to changing these alarming statistics.

In support of Lung Cancer Awareness Month, Boston Scientific will donate 1% of select Pulmonary Device and Airway Stent sales made in November to The American Lung Association to help fund lung cancer awareness and research. 

Program Details:

Boston Scientific will donate 1% of Pulmonary Devices (excluding Bronchial Thermoplasty) and Airway Stents sales during the month of November to The American Lung Association, with a maximum donation amount of $15,000. This program applies to all Pulmonary devices (excluding Bronchial Thermoplasty) and airway stents sold from November 1-30, 2017. The Program is subject to modification or termination by Boston Scientific without prior notification. This program may not be available in all countries. Contact your Territory Manager for details of the Program.